Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Making oncology global with the WIN consortium

Share :
Published: 25 Apr 2019
Views: 1453
Rating:
Save
Dr Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain

Dr Josep Tabernero speaks with ecancer about the mission and history of the WIN consortium.

He focusses on the challenges surrounding the implementation of precision oncology on a global level, and what innovative solutions the WIN consortium is taking to achieve this.

He also outlines the future for the WIN consortium, and why the WIN Symposium 2019 will be an important meeting to attend.

Related Videos

ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale...
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus ( Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale Tomasini )
25 Mar 2024
Multiple myeloma in a resource constrained setting
Dr Henry Ddungu - Uganda Cancer Institute, Kampala, Uganda
Multiple myeloma in a resource constrained setting ( Dr Henry Ddungu - Uganda Cancer Institute, Kampala, Uganda )
22 Feb 2024
First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic...
Prof Eileen M O’Reilly - Memorial Sloan Kettering Cancer Center, New York City...
First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer ( Prof Eileen M O’Reilly - Memorial Sloan Kettering Cancer Center, New York City, USA )
15 Jun 2023
Choosing Wisely in radiology Tanzania
Dr Revelian Iramu - Ocean Road Cancer Institute, Dar es Salaam, Tanzania
Choosing Wisely in radiology Tanzania ( Dr Revelian Iramu - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )
18 May 2023
The advantages of IORT for early breast cancer treatment
Dr David Martinez Perez - AUNA, Lima, Peru
The advantages of IORT for early breast cancer treatment ( Dr David Martinez Perez - AUNA, Lima, Peru )
26 Apr 2023
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+...
Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )
28 Mar 2023
Moving to the future: Artificial intelligence in surgery
Dr Maria João Cardoso - Champalimaud Cancer Centre, Lisbon, Portugal
Moving to the future: Artificial intelligence in surgery ( Dr Maria João Cardoso - Champalimaud Cancer Centre, Lisbon, Portugal )
31 Jan 2023
Systemic anti-cancer performance matrix
Prof Richard Sullivan, Kari Leung and Megan McLeod
Systemic anti-cancer performance matrix ( Prof Richard Sullivan, Kari Leung and Megan McLeod )
23 Nov 2022
An overview of treatment advances in gastric cancer
Prof David Ilson - Memorial Sloan Kettering Cancer Center, New York City, USA
An overview of treatment advances in gastric cancer ( Prof David Ilson - Memorial Sloan Kettering Cancer Center, New York City, USA )
18 Aug 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation